| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/27/2001 | US6193864 Locking sensor cartridge with integral fluid ports, electrical connections, and pump tube |
| 02/27/2001 | US6193675 Fluid sampling apparatus |
| 02/27/2001 | US6193667 Methods of determining the effect(s) of materials, conditions, activities and lifestyles |
| 02/27/2001 | US6192891 Integrated system including medication delivery pen, blood monitoring device, and lancer |
| 02/27/2001 | US6192766 Apparatus, system and method for the detection of an analyte in air |
| 02/27/2001 | US6192763 Method and apparatus for determining the strength path of a mortar or concrete mix |
| 02/27/2001 | US6192750 Process sensor assembly and sensor mount |
| 02/27/2001 | US6192738 Method and arrangement for analyzing exhaust gas from an internal combustion engine |
| 02/27/2001 | US6192737 Method for measuring the concentration of a dissolved gas in a fluid |
| 02/27/2001 | CA2096654C Removal of antibodies from blood-derived compositions while retaining coagulation factors |
| 02/27/2001 | CA2084492C Multivalent dextran reagent for use in precipitation tests |
| 02/27/2001 | CA2069508C Method and apparatus for measuring fibre flexibility |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/26/2001 | CA2281010A1 Diagnostic method |
| 02/22/2001 | WO2001013432A1 Sensing devices using chemically-gated single electron transistors |
| 02/22/2001 | WO2001013127A1 Analyzing cartridge and liquid feed control device |
| 02/22/2001 | WO2001013126A1 Microelectronic molecular descriptor array devices, methods, procedures, and formats for combinatorial selection of intermolecular ligand binding structures and for drug screening |
| 02/22/2001 | WO2001013125A1 A method for predicting the presence of haemostatic dysfunction in a patient sample |
| 02/22/2001 | WO2001013124A1 Method for controlling the quality of the endothelium lining of blood vessels prostheses |
| 02/22/2001 | WO2001013123A2 Method for indirectly determining the blood-clotting status |
| 02/22/2001 | WO2001013122A2 Method for monitoring beta tubulin isotype modification |
| 02/22/2001 | WO2001013121A1 Methods for identification of compounds stimulating insulin secretion |
| 02/22/2001 | WO2001013120A1 Microparticles with multiple fluorescent signals and methods of using same |
| 02/22/2001 | WO2001013119A1 Encapsulation of fluorescent particles |
| 02/22/2001 | WO2001013118A2 Methods and compositions for diagnosis of hepatoma |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001013116A1 Internally referenced immunoassay and test device |
| 02/22/2001 | WO2001013115A2 Method and device for identifying a biopolymer sequence on a solid surface |
| 02/22/2001 | WO2001013114A1 Use of stabilised synthetic compounds in immunoassay |
| 02/22/2001 | WO2001013113A1 Methods and compositions for modulating somatolactogenic functions |
| 02/22/2001 | WO2001013111A2 Allele detection of pgm1, gc, and aat |
| 02/22/2001 | WO2001013110A2 Detection of isomerised epitopes in autoimmune diseases |
| 02/22/2001 | WO2001013109A2 Diapers containing chemical reagents for urine testing |
| 02/22/2001 | WO2001013108A1 Method for identifying modulating compounds of neurotransmitters |
| 02/22/2001 | WO2001013107A1 Method for measuring the temperature and moisture of a web |
| 02/22/2001 | WO2001013103A1 Analytical apparatus and method |
| 02/22/2001 | WO2001013102A1 Sensor devices and analytical methods for their use |
| 02/22/2001 | WO2001013101A1 Gas sensor |
| 02/22/2001 | WO2001013097A1 pH SENSOR FOR INDICATING THE pH OF A SAMPLE, THE FABRICATION AND USE THEREOF |
| 02/22/2001 | WO2001013096A1 Device and method for determining multiple analytes |
| 02/22/2001 | WO2001013095A1 Method for luminescence measurements |
| 02/22/2001 | WO2001013089A1 Method and device for determining fluidity of fluid in container |
| 02/22/2001 | WO2001013088A1 Methods and apparatuses for stretching polymers |
| 02/22/2001 | WO2001013087A2 Sensors and sensor arrays of conducting and insulating composites and methods of use thereof |
| 02/22/2001 | WO2001012859A2 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 02/22/2001 | WO2001012856A2 Analysis of sequence tags with hairpin primers |
| 02/22/2001 | WO2001012855A2 Binary encoded sequence tags |
| 02/22/2001 | WO2001012854A2 Color compensation for temperature and electronic gains |
| 02/22/2001 | WO2001012852A2 Polymerase extension at 3' terminus of pna-dna chimera |
| 02/22/2001 | WO2001012848A2 Genetic marker for rheumatoid arthritis |
| 02/22/2001 | WO2001012846A1 Preparation of metal oxide supports loaded with biomolecules |
| 02/22/2001 | WO2001012840A2 Anti-epha2 antibodies as a cancer diagnostic |
| 02/22/2001 | WO2001012839A1 Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012813A1 Gene encoding merozoite protein of babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012785A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012778A2 Flocculation of cell material |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012757A1 Use of 13c nmr spectroscopy to produce optimum fischer-tropsch diesel fuels and blend stocks |
| 02/22/2001 | WO2001012727A1 Detection of polyhydroxyl compounds |
| 02/22/2001 | WO2001012699A1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012575A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 02/22/2001 | WO2001012325A1 Method and apparatus for directly sampling a fluid for microfiltration |
| 02/22/2001 | WO2001012237A1 Support materials and imaging method for intraoral diagnostic purposes |
| 02/22/2001 | WO2001012219A1 Pneumococcal vaccines |
| 02/22/2001 | WO2001012212A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | WO2001012211A1 Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers |
| 02/22/2001 | WO2001012210A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | WO2001012182A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2001012170A2 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/22/2001 | WO2001011953A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000077246A3 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000073793A3 Identification of compounds modulating insulin receptor activity |
| 02/22/2001 | WO2000073330A3 Method and compositions relating to insulin resistance disorders |
| 02/22/2001 | WO2000072877A8 Rapid immunoassay to detect antibodies in saliva to disease-related antigens |
| 02/22/2001 | WO2000072742A3 Methods and materials for generating sh3 domains with tailored binding properties |
| 02/22/2001 | WO2000072008A3 Identification of novel mechanisms of drug resistance |
| 02/22/2001 | WO2000071995A3 Encoding and decoding of array sensors utilizing nanocrystals |
| 02/22/2001 | WO2000065344A3 Biological indicators for validating a prion sterilization-process |
| 02/22/2001 | WO2000064936A3 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
| 02/22/2001 | WO2000057192A3 Reversible-flow conduit system |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000054882A8 Individually addressable micro-electromagnetic unit array chips |